HCP Transfer of Value Reporting
As a member of Medicines Australia, Novo Nordisk has undertaken to be open and transparent when we provide a reportable payment or transfer of value to a healthcare professional. Reportable payments or transfers of value are:
- Payments for the provision of services such as giving a lecture, chairing an educational meeting, providing advice as a member of an Advisory Board or as a Consultant.
- Airfares, accommodation and/or conference registration fees to attend medical education as part of those services.
Novo Nordisk has prepared the reports for publication in accordance with the Medicines Australia Code of Conduct, Edition 18 and Australia's Privacy legislation. The reports identify healthcare professionals by name where their consent has been provided. Where consent has not been provided the information is reported in aggregate.
From 1 October 2016, reporting these payments is mandatory - details will be reported because healthcare professionals should reasonably expect that all reportable payments or transfers of value will be disclosed for each healthcare professional, by name.
The reports are designed to be read on this website. They are also provided as downloadable CSV files.
To comply with our privacy obligations, the reports may be amended from time to time. The reports contain the most up to date information. Any use or disclosure of the data by a third party is the responsibility of that third party, who must comply with the Australian Privacy Act 1988. For further information about the details in the reports, please go to medicinesaustralia.com.au
HCP Payments and Transfer of Value (ToV) Reports
Last Updated: 28 February 2017